Physician

Min-Kyu Han, M.D.

According to 2025 Medicare claims, Min-Kyu Han, M.D. (NPI: 1912901877) practices ophthalmology in the Peoria, IL market, with the plurality of this provider's patient population coming from Tazewell, IL. This provider's primary affiliated billing organization is WYMAN SICHER EYE ASSOCIATES SC (NPI: 1679593123; TIN: 370949256) and primary practice location at 61615-7822. Han is affiliated with the IRCCO (ACO ID: A2619), participating under the MSSP model.

Han's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,289 traditional Medicare patients, billed 144,353 HCPCS/CPT codes, and received $5,664,856 in Medicare payments. The top billing code was 67028 (Injection of drug into eye). Part D data shows 916 prescription claims across 242 beneficiaries totaling $48,585 in drug costs, led by Prednisolone Acetate (Prednisolone Acetate). Open Payments data shows 5 records totaling $3,252. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $912,497 to $5,664,856. Concurrently, Part D prescription costs have changed little. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$2.8M$5.7M2015 Medicare payment: $912,497 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $1,031,507 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $1,426,196 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $1,769,006 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $2,266,367 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $2,555,646 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $3,315,310 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $4,331,524 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $4,985,333 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $5,664,856 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20151,28410,603$912,497
20161,39111,636$1,031,507
20171,62313,293$1,426,196
20181,58814,011$1,769,006
20191,50615,396$2,266,367
20201,47113,594$2,555,646
20211,62915,548$3,315,310
20221,54829,852$4,331,524
20231,37495,303$4,985,333
20241,289144,353$5,664,856

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$32K$64K2015 Drug cost: $43,660 (USD; Tot_Drug_Cst)2016 Drug cost: $38,767 (USD; Tot_Drug_Cst)2017 Drug cost: $44,004 (USD; Tot_Drug_Cst)2018 Drug cost: $43,558 (USD; Tot_Drug_Cst)2019 Drug cost: $47,686 (USD; Tot_Drug_Cst)2020 Drug cost: $55,622 (USD; Tot_Drug_Cst)2021 Drug cost: $64,122 (USD; Tot_Drug_Cst)2022 Drug cost: $49,939 (USD; Tot_Drug_Cst)2023 Drug cost: $57,331 (USD; Tot_Drug_Cst)2024 Drug cost: $48,585 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015139469$43,660
2016154462$38,767
2017172503$44,004
2018157474$43,558
2019168492$47,686
2020141513$55,622
2021175633$64,122
2022194728$49,939
2023213790$57,331
2024242916$48,585

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
67028Injection of drug into eye7053,214$92
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more7231,282$91
92014Established patient complete exam of visual system584719$78
92134Imaging of retina1,2174,131$29
J2777Injection, faricimab-svoa, 0.1 mg450128,280$27

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Prednisolone AcetatePrednisolone Acetate37415,329$15,435
LumiganBimatoprost11380$3,644
Ketorolac TromethamineKetorolac Tromethamine2018,054$2,758
LatanoprostLatanoprost864,562$715
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat472,470$520

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.4$252Bausch & Lomb Americas Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.1$3,000Astellas Pharma Global Development
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Min-Kyu Han, M.D.?

Tedicare shows public-source Medicare data for Min-Kyu Han, M.D. (NPI 1912901877), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Min-Kyu Han, M.D. have ACO affiliation data?

Min-Kyu Han, M.D. is shown with ACO affiliation data for IRCCO (MSSP, ACO ID A2619).

What billing organization is linked to Min-Kyu Han, M.D.?

Min-Kyu Han, M.D. is linked to WYMAN SICHER EYE ASSOCIATES SC (billing NPI 1679593123) in the available physician profile data.

Does Min-Kyu Han, M.D. have Open Payments data?

Min-Kyu Han, M.D. has 5 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.